← Back to all trials
Not Yet Recruiting
NCT07579156
TearCare in Young Adults
Conditions: Meibomian Gland Dysfunction (Disorder)
Sex: All
Ages: 18 Years – 29 Years
Healthy volunteers: No
Phase: NA
Enrollment: 45
Sponsor: University of Alabama at Birmingham
Location: University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility Birmingham Alabama
Summary
This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare® performed at Visit 1. A single follow-up examination occurs at Day 28.
Eligibility Criteria
Inclusion Criteria:
1. Age ≥18 years but \
Source: ClinicalTrials.gov (NCT07579156). StuddyBuddy aggregates publicly available trial information.
